Clostridium difficile-associated diarrhea

被引:10
作者
Bujanda, Luis [1 ]
Cosme, Angel [2 ]
机构
[1] Hosp Donostia, Serv Aparato Digest, Ctr Invest Biomed Enfermedades Hepat & Digest, CIBEREHD, San Sebastian, Spain
[2] Univ Basque Country, Inst Salud Carlos III, San Sebastian, Spain
来源
GASTROENTEROLOGIA Y HEPATOLOGIA | 2009年 / 32卷 / 01期
关键词
Clostridium difficile; Diagnosis; Treatment; Diarrhea; Antibiotics; INTRAVENOUS IMMUNOGLOBULIN; CASE SERIES; COLITIS; VANCOMYCIN; DISEASE; OUTCOMES; METRONIDAZOLE; PREVENTION; DIAGNOSIS; TOLEVAMER;
D O I
10.1016/j.gastrohep.2008.02.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Clostridium difficile is the most frequent cause of nosocomial diarrhea and is a significant cause of morbidity among hospitalized patients. The inflammation is produced as a result of a non-specific response to toxins. In the last few years, a hypervirulent strain, NAP1/BI/027, has been reported. Symptoms usually consist of abdominal pain and diarrhea. The diagnosis should be suspected in any patient who develops diarrhea during antibiotic therapy or 6-8 weeks after treatment. Diagnosis should be confirmed by the detection of CD toxin in stool and by colonoscopy in special situations. The treatment of choice is metronidazole or vancomycin. In some patients who do not respond to this therapy or who have complications, subtotal colectomy may be required. Relapse is frequent and must be distinguished from reinfection. Prevention and control in healthcare settings requires careful attention. © 2008 Elsevier España, S.L. All rights reserved.
引用
收藏
页码:48 / 56
页数:9
相关论文
共 49 条
[1]   Recurrent Clostridium difficile colitis:: Case series involving 18 patients treated with donor stool administered via a nasogastric tube [J].
Aas, J ;
Gessert, CE ;
Bakken, JS .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (05) :580-585
[2]   Fulminant Clostridium difficile colitis [J].
Adams, Sasha D. ;
Mercer, David W. .
CURRENT OPINION IN CRITICAL CARE, 2007, 13 (04) :450-455
[3]   CLOSTRIDIUM-DIFFICILE INFECTION ASSOCIATED WITH ANTINEOPLASTIC CHEMOTHERAPY - A REVIEW [J].
ANAND, A ;
GLATT, AE .
CLINICAL INFECTIOUS DISEASES, 1993, 17 (01) :109-113
[4]   Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis:: Case series and review of the literature [J].
Apisarnthanarak, A ;
Razavi, B ;
Mundy, LM .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (06) :690-696
[5]   ANTIMICROBIAL AGENTS AND CLOSTRIDIUM-DIFFICILE IN ACUTE ENTERIC DISEASE - EPIDEMIOLOGICAL DATA FROM SWEDEN, 1980-1982 [J].
ARONSSON, B ;
MOLLBY, R ;
NORD, CE .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (03) :476-481
[6]   Review article: tolevamer, a novel toxin-binding polymer: overview of preclinical pharmacology and physicochemical properties [J].
Barker, R. H., Jr. ;
Dagher, R. ;
Davidson, D. M. ;
Marquis, J. K. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (11-12) :1525-1534
[7]   The challenges posed by reemerging Clostridium difficile infection [J].
Blossom, David B. ;
McDonald, L. Clifford .
CLINICAL INFECTIOUS DISEASES, 2007, 45 (02) :222-227
[8]  
BORDELLO SP, 1983, J CLIN PATHOL, V36, P84
[9]   Evaluation of three methods of diagnosis of Clostridium difficile infection [J].
Calvo, J ;
Zarrabeitia, R ;
García-Palamo, D ;
Fariñas, MC ;
Agüero, J .
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2001, 19 (04) :184-186
[10]  
de Isusi AM, 2003, MED CLIN-BARCELONA, V121, P331, DOI 10.1157/13050841